Mike Evers, Author at ORTHOWORLD

Globus Medical Encouraged by Early Integration Efforts

The company grew more than 50% in the third quarter of 2023 as it benefit from continued share growth and a month of NuVasive sales.

Nov 08, 2023

The company grew more than 40% in the third quarter of 2023 as it procedural solutions continue winning significant market share.

Nov 07, 2023

The company grew nearly 29% in the third quarter of 2023, notching its sixth consecutive quarter of record revenues.

Nov 07, 2023

The company grew in the high-single-digits in the third quarter of 2023, driven by market recovery and improving operational performance.

Nov 06, 2023

The company grew in the mid-single-digits for the third quarter of 2023, driven by new products and better-than-expected orthobiologics sales.

Nov 06, 2023

The company grew in the high-single-digits in the third quarter of 2023, driven by new products and robotic procedures.

Nov 03, 2023

The company's 3Q23 orthopedic sales declined by nearly 10% due to continued competitive pressure and an exit from the Chinese market.

Nov 02, 2023

Company President and CEO Stuart Simpson talks about the barriers to robotic adoption, the development of TMINI and open robotics.

Oct 30, 2023

The company's orthopedic sales grew in the mid-single-digits for the third quarter of 2023 and displayed newfound resiliency.

Oct 27, 2023

Over the last twelve months, investors focused more heavily on enabling technology as the orthopedic market further embraces digital.

Oct 18, 2023